<?xml version="1.0" encoding="UTF-8"?>
<ref id="B3-antioxidants-09-01083">
 <label>3.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hammond</surname>
    <given-names>T.C.</given-names>
   </name>
   <name>
    <surname>Xing</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Ma</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Nho</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Crane</surname>
    <given-names>P.K.</given-names>
   </name>
   <name>
    <surname>Elahi</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Ziegler</surname>
    <given-names>D.A.</given-names>
   </name>
   <name>
    <surname>Liang</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Cheng</surname>
    <given-names>Q.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>β-amyloid and tau drive early Alzheimer’s disease decline while glucose hypometabolism drives late decline</article-title>
  <source>Commun. Biol.</source>
  <year>2020</year>
  <volume>3</volume>
  <fpage>1</fpage>
  <lpage>13</lpage>
  <pub-id pub-id-type="doi">10.1038/s42003-020-1079-x</pub-id>
  <pub-id pub-id-type="pmid">31925316</pub-id>
 </element-citation>
</ref>
